Molecular and metabolic imaging of atherosclerosis.
暂无分享,去创建一个
[1] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[2] R. Taillefer,et al. Imaging characteristics of a novel technetium Tc 99m-labeled platelet glycoprotein IIb/IIIa receptor antagonist in patients With acute deep vein thrombosis or a history of deep vein thrombosis. , 2003, Archives of internal medicine.
[3] P. Ganz,et al. Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.
[4] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[5] G. D. De Meyer,et al. In Vivo Temperature Heterogeneity of Atherosclerotic Plaques Is Determined by Plaque Composition , 2002, Circulation.
[6] René M. Botnar,et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.
[7] R. Wahl,et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) , 2001, Nuclear medicine communications.
[8] Werner Moshage,et al. Detection of Coronary Artery Stenoses by Contrast-Enhanced, Retrospectively Electrocardiographically-Gated, Multislice Spiral Computed Tomography , 2001, Circulation.
[9] A. Alavi,et al. F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.
[10] D. Waters,et al. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model. , 2000, Circulation.
[11] P Toutouzas,et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. , 1999, Circulation.
[12] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[13] Ignasi Carrió,et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells , 1998, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[14] M. Bennett,et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. , 1998, Circulation research.
[15] M. Bennett,et al. Thrombin generation by apoptotic vascular smooth muscle cells. , 1997, Blood.
[16] M J Davies,et al. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.
[17] G. Ronga,et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. , 1996, Atherosclerosis.
[18] V. Fuster,et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.
[19] V. Fuster,et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. , 1996, Circulation.
[20] G Baumann,et al. Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. , 1996, Journal of the American College of Cardiology.
[21] W. Vaughn,et al. Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. , 1996, Journal of the American College of Cardiology.
[22] L. Knight,et al. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] C J Slager,et al. Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? , 1995, Atherosclerosis.
[24] N. Oku,et al. Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[25] M. Cerqueira,et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. , 1995, Circulation.
[26] M J Davies,et al. Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention. , 1995, European heart journal.
[27] J. Rumberger,et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. , 1995, Circulation.
[28] V. Fuster,et al. T2-weighted contrast for NMR characterization of human atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[29] A. Fox,et al. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. , 1995, Stroke.
[30] R. Edelman,et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? , 1995, Stroke.
[31] Y. Uchida,et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. , 1995, American heart journal.
[32] K. Spicer,et al. Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbits. , 1995, Nuclear medicine and biology.
[33] V. Torchilin,et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. , 1995, Circulation.
[34] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[35] M. G. Walker,et al. Indium‐111 platelet scintigraphy in vascular disease , 1995, The British journal of surgery.
[36] J. Seabold,et al. Will a radiolabeled antibody replace indium-111-platelets to detect active thrombus? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] M. Cerqueira,et al. Imaging arterial thrombosis: comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-platelets. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] A. Maseri,et al. Vasoreactivity of the Culprit Lesion in Unstable Angina , 1994, Circulation.
[39] P. Serruys,et al. The 'Ermenonville' classification of observations at coronary angioscopy--evaluation of intra- and inter-observer agreement. European Working Group on Coronary Angioscopy. , 1994, European heart journal.
[40] H Sinzinger,et al. Evidence for Lipid Regression in Humans In Vivo Performed by 123Iodine‐Low‐Density Lipoprotein Scintiscanning , 1994, Annals of the New York Academy of Sciences.
[41] I. Ferrer,et al. Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury , 1993, European Journal of Nuclear Medicine.
[42] R. Lees,et al. External Imaging of Atherosclerosis in Rabbits Using an 123I‐Labeled Synthetic Peptide Fragment , 1993, Journal of clinical pharmacology.
[43] P. Demacker,et al. Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] L. Knight. Scintigraphic methods for detecting vascular thrombus. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] R. Lees,et al. Time course of 125I-labeled LDL accumulation in the healing, balloon-deendothelialized rabbit aorta. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[46] J. Salonen,et al. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[47] L G Strauss,et al. The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] J. Tait,et al. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. , 1990, The Journal of biological chemistry.
[49] M J Davies,et al. A macro and micro view of coronary vascular insult in ischemic heart disease. , 1990, Circulation.
[50] P. Alderson,et al. Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[51] U. Steinbrecher,et al. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. , 1989, The Journal of biological chemistry.
[52] V. Fuster,et al. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. , 1988, Journal of the American College of Cardiology.
[53] A. Fischman,et al. Imaging Human Atherosclerosis with 99mTc‐labeled Low Density Lipoproteins , 1988, Arteriosclerosis.
[54] V. Fuster,et al. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] R. Anholt,et al. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.
[56] E. Hoffman,et al. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] K. Ericson,et al. DETECTION OF ATHEROSCLEROTIC PLAQUES IN CAROTID ARTERIES BY THE USE OF 123I-FIBRINOGEN , 1978, The Lancet.
[58] W. Edwards. Blood Vessels , 1959 .
[59] P. Angelberger,et al. Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage , 2004, European Journal of Nuclear Medicine.
[60] A. Alavi,et al. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.
[61] P Toutouzas,et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. , 2000, Journal of molecular and cellular cardiology.
[62] J. Witztum,et al. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[63] R. Lees,et al. Radiopharmaceutical Imaging of Atherosclerosis , 1996 .
[64] V. Fuster. Syndromes of atherosclerosis : correlations of clinical imaging and pathology , 1996 .
[65] T. Ido,et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] T. Lüscher,et al. Endothelial dysfunction in coronary artery disease. , 1993, Annual review of medicine.
[67] T. Lüscher,et al. Endothelium-dependent contractions. , 1991, Blood vessels.
[68] R. Ahmadi,et al. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. , 1989, Stroke.
[69] T. Carew,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[70] R. Ross,et al. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.
[71] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.